(Q33696453)

English

Low serum paraoxonase: a risk factor for atherosclerotic disease?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

Low serum paraoxonase: a risk factor for atherosclerotic disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Mackness MI

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Durrington PN

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ayub A

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mackness B

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chemico-biological Interactions

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

119-120

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

389-397

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

HDL, its enzymes and its potential to influence lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta Hutterites

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Presence of paraoxonase in human interstitial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900050-2

7 January 2021

Identifiers

10.1016/S0009-2797(99)00050-2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

release_qjkx5cw67fcmrng7ox2xlsze3a

1 reference

https://api.fatcat.wiki/v0/release/qjkx5cw67fcmrng7ox2xlsze3a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33696453&oldid=1837200626"